The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 31 July 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 154K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, P. R.
Right arrow Articles by Walport, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, P. R.
Right arrow Articles by Walport, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/8/359/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 3, August 7, 2000 359-366


Original Article

A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells In Vivo

Philip R. Taylora, Anna Carugatia, Valerie A. Fadokc, H. Terence Cookb, Mark Andrewsd, Michael C. Carrolle, John S. Savillf, Peter M. Hensonc, Marina Bottoa, and Mark J. Walporta
a Rheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
b Department of Histopathology, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
c Department of Pediatrics, National Jewish Medical Research Center, Denver, Colorado 80206
d Division of Renal and Inflammatory Disease, University Hospital, Nottingham NG7 2UH, United Kingdom
e Center for Blood Research, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02165
f Centre for Inflammation Research, University of Edinburgh Medical School, Edinburgh EH3 9YW, United Kingdom

Correspondence to: Mark J. Walport, Rheumatology Section, Div. of Medicine, Imperial College School of Medicine, Hammersmith Campus, Du Cane Rd., London W12 0NN, UK. Tel:44-20-8383-3299 Fax:44-20-8743-3109 E-mail:m.walport{at}ic.ac.uk.

The strongest susceptibility genes for the development of systemic lupus erythematosus (SLE) in humans are null mutants of classical pathway complement proteins. There is a hierarchy of disease susceptibility and severity according to the position of the missing protein in the activation pathway, with the severest disease associated with C1q deficiency. Here we demonstrate, using novel in vivo models of apoptotic cell clearance during sterile peritonitis, a similar hierarchical role for classical pathway complement proteins in vivo in the clearance of apoptotic cells by macrophages. Our results constitute the first demonstration of an impairment in the phagocytosis of apoptotic cells by macrophages in vivo in a mammalian system. Apoptotic cells are thought to be a major source of the autoantigens of SLE, and impairment of their removal by complement may explain the link between hereditary complement deficiency and the development of SLE.

Key Words: systemic lupus erythematosus, complement deficiency, C1q, transgenic mice, apoptosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS